Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hilde Haugedal Nordal, Magne K. Fagerhol, Anne-Kristine Halse & Hilde Berner Hammer. (2018) Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis. Scandinavian Journal of Clinical and Laboratory Investigation 78:1-2, pages 102-108.
Read now
Read now
Ulla Bregendahl Nielsen, Laerke Valsøe Bruhn, Torkell Ellingsen, Kristian Stengaard-Pedersen & Nete Hornung. (2018) Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate. Scandinavian Journal of Clinical and Laboratory Investigation 78:1-2, pages 62-67.
Read now
Read now
Sang-Cheol Bae & Young Ho Lee. (2017) Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. Postgraduate Medicine 129:5, pages 531-537.
Read now
Read now
HH Nordal, JG Brun, M Hordvik, M Eidsheim, R Jonsson & A-K Halse. (2016) Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab. Scandinavian Journal of Rheumatology 45:4, pages 274-281.
Read now
Read now
Eva Klingberg, Hans Carlsten, Elisabet Hilme, Martin Hedberg & Helena Forsblad-d'Elia. (2012) Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum. Scandinavian Journal of Gastroenterology 47:4, pages 435-444.
Read now
Read now
M Tamai, A Kawakami, N Iwamoto, K Arima, K Aoyagi & K Eguchi. (2010) Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. Scandinavian Journal of Rheumatology 39:4, pages 287-291.
Read now
Read now
Articles from other publishers (21)
Jutta S Swolinsky, Ricarda M Hinz, Carolin E Markus, Eugenia Singer, Friederike Bachmann, Fabian Halleck, Susanne Kron, Marcel G Naik, Danilo Schmidt, Martin Obermeier, Pimrapat Gebert, Geraldine Rauch, Siegfried Kropf, Michael Haase, Klemens Budde, Kai-Uwe Eckardt, Timm H Westhoff & Kai M Schmidt-Ott. (2023) Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss. Nephrology Dialysis Transplantation.
Crossref
Crossref
Samantha Louise Smith, Sheree Alexander, Nisha Nair, Sebastien Viatte, Stephen Eyre, Kimme L Hyrich, Ann W Morgan, Anthony G Wilson, John D Isaacs, Darren Plant & Anne Barton. (2023) Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Annals of the Rheumatic Diseases 82:5, pages 611-620.
Crossref
Crossref
Jiashun Zeng, Xiaoxia Liu, Jun Liu, Pengjia Wu & Lei Yang. (2022) Linkage of calprotectin with inflammation, activity and treatment response of rheumatoid arthritis: a meta-analysis. Biomarkers in Medicine 16:17, pages 1239-1249.
Crossref
Crossref
Mona H. Abd Elsamea, Safaa A. Mahran, Asmaa N. Badr, Dalia T. Kamal & Tayseer M. Khidre. (2022) Evaluation of serum calprotectin level as a biomarker of disease activity in rheumatoid arthritis and osteoarthritis patients. The Egyptian Rheumatologist 44:3, pages 185-190.
Crossref
Crossref
Gholam Hossein Alishiri, Ramezan Ali Ataee, Mahsa Ramezanpour, Danial Chaleshi & Ehsan Rahmanian. (2022) Correlation between Serum Levels of Calprotectin with Disease Activity in Rheumatoid Arthritis Patients. Journal of Advances in Medical and Biomedical Research 30:140, pages 263-268.
Crossref
Crossref
Ahmed R. Radwan, Ahmed Allam & Abdullah Radwan. (2021) The relationship of serum calprotectin with disease activity, functional status, ultrasonographic findings and radiological damage in rheumatoid arthritis patients. The Egyptian Rheumatologist 43:2, pages 147-151.
Crossref
Crossref
Mary Bach, Jeonghun Moon, Richard Moore, Tiffany Pan, J. Lee Nelson & Christian Lood. (2019) A Neutrophil Activation Biomarker Panel in Prognosis and Monitoring of Patients With Rheumatoid Arthritis. Arthritis & Rheumatology 72:1, pages 47-56.
Crossref
Crossref
Lieve Van Hoovels, Bert Vander Cruyssen, Laura Bogaert, Stefanie Van den Bremt & Xavier Bossuyt. (2019) Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis. Clinical Chemistry and Laboratory Medicine (CCLM) 58:1, pages 40-49.
Crossref
Crossref
Nicolas Jung, Véronique Schenten, Jean-Luc Bueb, Fabrice Tolle & Sabrina Bréchard. (2019) miRNAs Regulate Cytokine Secretion Induced by Phosphorylated S100A8/A9 in Neutrophils. International Journal of Molecular Sciences 20:22, pages 5699.
Crossref
Crossref
N. Jung, J.-L. Bueb, F. Tolle & S. Bréchard. (2019) Regulation of neutrophil pro-inflammatory functions sheds new light on the pathogenesis of rheumatoid arthritis. Biochemical Pharmacology 165, pages 170-180.
Crossref
Crossref
Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, Hilde Berner Hammer, Anna-Birgitte Aga, Inge Christoffer Olsen, Karl Albert Brokstad, Désirée van der Heijde, Tore K Kvien, Bjørg-Tilde Svanes Fevang, Siri Lillegraven & Espen A Haavardsholm. (2017) Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases 76:12, pages 2031-2037.
Crossref
Crossref
Francesca Ometto, Lara Friso, Davide Astorri, Costantino Botsios, Bernd Raffeiner, Leonardo Punzi & Andrea Doria. (2016) Calprotectin in rheumatic diseases. Experimental Biology and Medicine 242:8, pages 859-873.
Crossref
Crossref
Amal F. Soliman, Basant M. Elnady, Raneyah H. Mahmoud Shaker & Amira I. Mansour. (2016) Potential role of calprotectin as a monitoring biomarker for clinical and sonographic activity and treatment outcome in recent-onset rheumatoid arthritis. Egyptian Rheumatology and Rehabilitation 43:3, pages 143-149.
Crossref
Crossref
Tetsuro Yamasaki, Ryo Oda, Kan Imai, Daigo Taniguchi, Shogo Toyama, Takahiro Seno, Yuji Arai, Kazuya Ikoma, Hiroyoshi Fujiwara, Daisaku Tokunaga, Yutaka Kawahito & Toshikazu Kubo. (2016) Efficacy of MRP8/14 as a Marker of Disease Activity in Rheumatoid Arthritis. Open Journal of Rheumatology and Autoimmune Diseases 06:02, pages 34-39.
Crossref
Crossref
Joseph P. Zackular, Walter J. Chazin & Eric P. Skaar. (2015) Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface. Journal of Biological Chemistry 290:31, pages 18991-18998.
Crossref
Crossref
Mads Abildtrup, Gabrielle H. Kingsley & David L. Scott. (2015) Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review. The Journal of Rheumatology 42:5, pages 760-770.
Crossref
Crossref
Kwi Young KangJung-Won WooSung-Hwan Park. (2014) S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis. The Korean Journal of Internal Medicine 29:1, pages 12.
Crossref
Crossref
Miriam García-Arias, Dora Pascual-Salcedo, Susana Ramiro, Marie-Eve Ueberschlag, Thomas M. Jermann, Carlos Cara, Emilio Martín-Mola & Alejandro Balsa. (2013) Calprotectin in Rheumatoid Arthritis. Molecular Diagnosis & Therapy 17:1, pages 49-56.
Crossref
Crossref
Ladislav Šenolt. (2012) Calprotectin (a S100 protein) as a sensitive biomarker for rheumatoid arthritis: new perspectives for an old finding. International Journal of Clinical Rheumatology 7:2, pages 127-129.
Crossref
Crossref
Lucie Andrés Cerezo, Heřman Mann, Ondřej Pecha, Lenka Pleštilová, Karel Pavelka, Jiří Vencovský & Ladislav Šenolt. (2011) Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Research & Therapy 13:4, pages R122.
Crossref
Crossref
Chandima Perera, H Patrick McNeil & Carolyn L Geczy. (2009) S100 Calgranulins in inflammatory arthritis. Immunology & Cell Biology 88:1, pages 41-49.
Crossref
Crossref